Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thilo Burkard

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Frontiers in Cardiovascular Medicine|August 1, 2022
Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)Isabella Sudano, Francois Mach, Tiziano Moccetti, et al.
Trials|April 20, 2023
Glucagon-like peptide-1 analogues: a new way to quit smoking? (SKIP)-a structured summary of a study protocol for a randomized controlled studySophia Lengsfeld, Thilo Burkard, Andrea Meienberg, et al.
JACC. Cardiovascular Imaging|September 22, 2014
Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudyMichael J Zellweger, Michael Maraun, Hans H Osterhues, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 13, 2023
Feasibility and measurement stability of smartwatch-based cuffless blood pressure monitoring: A real-world prospective observational studyMinju Han, Young-Ro Lee, Taeyoung Park, et al.
The American Journal of Cardiology|August 8, 2009
Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitationMihael Potocki, Johannes Mair, Michael Weber, et al.
The Journal of Clinical Endocrinology and Metabolism|May 16, 2019
Treatment of Primary Aldosteronism With mTORC1 InhibitorsBeckey Trinh, Matthias Hepprich, Matthias J Betz, et al.
Blood Pressure|April 25, 2022
Covid-19 associated reduction in hypertension-related diagnostic and therapeutic procedures in Excellence Centers of the European Society of HypertensionThomas Weber, Jaques Amar, Tine de Backer, et al.
Eclinicalmedicine|September 8, 2023
Head-to-head comparison of the WHO STEPwise approach with immediate unattended and delayed unattended automated blood pressure measurements during household-based screening: a diagnostic accuracy study in LesothoEmmanuel Firima, Lefokotsane Retselisitsoe, Ikhetheleng Leisa, et al.
Journal of Clinical Medicine|October 10, 2020
COVID-19 Triage and Test Center: Safety, Feasibility, and Outcomes of Low-Threshold TestingGregory Mansella, Marco Rueegg, Andreas F Widmer, et al.
Journal of Epidemiology and Global Health|October 26, 2023
High Rates of Undiagnosed Target Organ Damage Among Adults with Elevated Blood Pressure or Diabetes Mellitus in a Community-Based Survey in LesothoEmmanuel Firima, Lucia Gonzalez, Moazziz Ali Khan, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Frontiers in Cardiovascular Medicine|August 1, 2022
Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)Isabella Sudano, Francois Mach, Tiziano Moccetti, et al.
Trials|April 20, 2023
Glucagon-like peptide-1 analogues: a new way to quit smoking? (SKIP)-a structured summary of a study protocol for a randomized controlled studySophia Lengsfeld, Thilo Burkard, Andrea Meienberg, et al.
JACC. Cardiovascular Imaging|September 22, 2014
Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudyMichael J Zellweger, Michael Maraun, Hans H Osterhues, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 13, 2023
Feasibility and measurement stability of smartwatch-based cuffless blood pressure monitoring: A real-world prospective observational studyMinju Han, Young-Ro Lee, Taeyoung Park, et al.
The American Journal of Cardiology|August 8, 2009
Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitationMihael Potocki, Johannes Mair, Michael Weber, et al.
The Journal of Clinical Endocrinology and Metabolism|May 16, 2019
Treatment of Primary Aldosteronism With mTORC1 InhibitorsBeckey Trinh, Matthias Hepprich, Matthias J Betz, et al.
Blood Pressure|April 25, 2022
Covid-19 associated reduction in hypertension-related diagnostic and therapeutic procedures in Excellence Centers of the European Society of HypertensionThomas Weber, Jaques Amar, Tine de Backer, et al.
Eclinicalmedicine|September 8, 2023
Head-to-head comparison of the WHO STEPwise approach with immediate unattended and delayed unattended automated blood pressure measurements during household-based screening: a diagnostic accuracy study in LesothoEmmanuel Firima, Lefokotsane Retselisitsoe, Ikhetheleng Leisa, et al.
Journal of Clinical Medicine|October 10, 2020
COVID-19 Triage and Test Center: Safety, Feasibility, and Outcomes of Low-Threshold TestingGregory Mansella, Marco Rueegg, Andreas F Widmer, et al.
Journal of Epidemiology and Global Health|October 26, 2023
High Rates of Undiagnosed Target Organ Damage Among Adults with Elevated Blood Pressure or Diabetes Mellitus in a Community-Based Survey in LesothoEmmanuel Firima, Lucia Gonzalez, Moazziz Ali Khan, et al.
Pageof 8